Physician

Ashraf Uzzaman, M.D.

According to 2025 Medicare claims, Ashraf Uzzaman, M.D. (NPI: 1568624773) practices allergy/immunology, with the plurality of this provider's patient population coming from Lenawee, MI. This provider's primary affiliated billing organization is ASTHMA & ALLERGY CENTER, INC (NPI: 1710174271; TIN: 383792860) and primary practice location at 49286-1114.

Uzzaman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 27 traditional Medicare patients, billed 2,174 HCPCS/CPT codes, and received $55,660 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 603 prescription claims across 100 beneficiaries totaling $163,966 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). 2023 DME data shows 33 claims. Open Payments data shows 15 records totaling $321. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $77,658 to $55,660. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $109,139 to $163,966. For DME billing, this smaller-volume category started with an early spike, then settled into a lower baseline, moving from $3,789 to $525.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$96K$192K2015 Medicare payment: $77,658 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $115,259 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $104,136 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $191,764 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $191,680 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $164,683 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $156,686 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $181,362 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $133,033 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $55,660 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015943,843$77,658
20161255,334$115,259
2017984,490$104,136
2018998,524$191,764
2019947,876$191,680
2020596,074$164,683
2021685,936$156,686
2022636,713$181,362
2023414,861$133,033
2024272,174$55,660

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$137K$274K2015 Drug cost: $109,139 (USD; Tot_Drug_Cst)2016 Drug cost: $135,061 (USD; Tot_Drug_Cst)2017 Drug cost: $167,141 (USD; Tot_Drug_Cst)2018 Drug cost: $236,473 (USD; Tot_Drug_Cst)2019 Drug cost: $258,668 (USD; Tot_Drug_Cst)2020 Drug cost: $273,763 (USD; Tot_Drug_Cst)2021 Drug cost: $260,748 (USD; Tot_Drug_Cst)2022 Drug cost: $242,547 (USD; Tot_Drug_Cst)2023 Drug cost: $218,230 (USD; Tot_Drug_Cst)2024 Drug cost: $163,966 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015143826$109,139
2016158809$135,061
2017121768$167,141
2018131924$236,473
2019135935$258,668
2020119883$273,763
2021125761$260,748
2022128736$242,547
2023101545$218,230
2024100603$163,966

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$1.9K$3.8K2015 Medicare payment: $3,817 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $1,888 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $1,158 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $1,090 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $1,511 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $920 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $523 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $182 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $217 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
201586271$3,817
201656192$1,888
201731129$1,158
20182883$1,090
201935121$1,511
202012103$920
2021N/R40$523
2022N/R23$182
2023N/R33$217
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more2567$65
94010Test to measure expiratory airflow and volume2041$19

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Trelegy ElliptaFluticasone/Umeclidin/Vilanter934,590$95,498
Advair HfaFluticasone Propion/Salmeterol431,530$20,803
Breo ElliptaFluticasone/Vilanterol15630$7,848
Spiriva RespimatTiotropium Bromide13390$7,821
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate23720$5,627

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.15$321GENZYME CORPORATION
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ashraf Uzzaman, M.D.?

Tedicare shows public-source Medicare data for Ashraf Uzzaman, M.D. (NPI 1568624773), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ashraf Uzzaman, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ashraf Uzzaman, M.D.?

Ashraf Uzzaman, M.D. is linked to ASTHMA & ALLERGY CENTER, INC (billing NPI 1710174271) in the available physician profile data.

Does Ashraf Uzzaman, M.D. have Open Payments data?

Ashraf Uzzaman, M.D. has 15 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.